Cargando…
Intranasal Corticosteroids: Topical Potency, Systemic Activity and Therapeutic Index
Intranasal corticosteroid (INCS) therapy is the preferred treatment option for allergic rhinitis (AR). Although all INCSs for the treatment of AR are considered safe and effective, differences in potency, molecular structure features and physicochemical and pharmacokinetic properties could result in...
Autores principales: | Daley-Yates, Peter T, Larenas-Linnemann, Désirée, Bhargave, Chaitanya, Verma, Manish |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8436259/ https://www.ncbi.nlm.nih.gov/pubmed/34526783 http://dx.doi.org/10.2147/JAA.S321332 |
Ejemplares similares
-
Inhaled corticosteroids: potency, dose equivalence and therapeutic index
por: Daley-Yates, Peter T
Publicado: (2015) -
A Novel Approach to Assess the Potency of Topical Corticosteroids
por: Zvidzayi, Michael, et al.
Publicado: (2021) -
Knowledge and Attitude Among Patients and Physicians on Allergic Rhinitis (KAPPA): An International Survey
por: Bhargave, Chaitanya, et al.
Publicado: (2022) -
Deflazacort: therapeutic index, relative potency and equivalent doses versus other corticosteroids
por: Parente, Luca
Publicado: (2017) -
Endoscopic outcomes in patients with AERD treated with topical antibiotics and intranasal corticosteroids
por: Martinez-Paredes, Jhon F., et al.
Publicado: (2022)